Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease: A systematic review and meta-analysis

BACKGROUND: Pramipexole (P) or levodopa (L) treatment has been suggested as a therapeutic method for Parkinson disease (PD) in many clinical studies. Nonetheless, the combined effects of 2 drugs for PD patients are not completely understood. The aim of this research was to evaluate the clinical effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Jiang, De-Qi, Lu, Cheng-Shu, Li, Ming-Xing, Jiang, Li-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568447/
https://www.ncbi.nlm.nih.gov/pubmed/34871213
http://dx.doi.org/10.1097/MD.0000000000027511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568447/
https://www.ncbi.nlm.nih.gov/pubmed/34871213
http://dx.doi.org/10.1097/MD.0000000000027511

Ejemplares similares